vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.

First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $16.0M, roughly 1.6× CVRx, Inc.). First Bancorp, Inc runs the higher net margin — 39.4% vs -74.5%, a 113.8% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs 4.4%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-9.8M). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs 18.1%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

CVRX vs FNLC — Head-to-Head

Bigger by revenue
FNLC
FNLC
1.6× larger
FNLC
$25.8M
$16.0M
CVRX
Growing faster (revenue YoY)
FNLC
FNLC
+13.1% gap
FNLC
17.5%
4.4%
CVRX
Higher net margin
FNLC
FNLC
113.8% more per $
FNLC
39.4%
-74.5%
CVRX
More free cash flow
FNLC
FNLC
$44.4M more FCF
FNLC
$34.6M
$-9.8M
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
18.1%
FNLC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
FNLC
FNLC
Revenue
$16.0M
$25.8M
Net Profit
$-11.9M
$10.2M
Gross Margin
86.3%
Operating Margin
-69.8%
48.1%
Net Margin
-74.5%
39.4%
Revenue YoY
4.4%
17.5%
Net Profit YoY
-12.0%
39.7%
EPS (diluted)
$-0.45
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
FNLC
FNLC
Q4 25
$16.0M
$25.8M
Q3 25
$14.7M
$24.5M
Q2 25
$13.6M
$22.5M
Q1 25
$12.3M
$21.8M
Q4 24
$15.3M
$22.0M
Q3 24
$13.4M
$20.5M
Q2 24
$11.8M
$19.2M
Q1 24
$10.8M
$18.5M
Net Profit
CVRX
CVRX
FNLC
FNLC
Q4 25
$-11.9M
$10.2M
Q3 25
$-12.9M
$9.1M
Q2 25
$-14.7M
$8.1M
Q1 25
$-13.8M
$7.1M
Q4 24
$-10.7M
$7.3M
Q3 24
$-13.1M
$7.6M
Q2 24
$-14.0M
$6.2M
Q1 24
$-22.2M
$6.0M
Gross Margin
CVRX
CVRX
FNLC
FNLC
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
FNLC
FNLC
Q4 25
-69.8%
48.1%
Q3 25
-83.5%
45.2%
Q2 25
-105.8%
43.7%
Q1 25
-108.8%
39.3%
Q4 24
-67.0%
39.5%
Q3 24
-97.3%
44.6%
Q2 24
-118.3%
38.8%
Q1 24
-206.4%
39.3%
Net Margin
CVRX
CVRX
FNLC
FNLC
Q4 25
-74.5%
39.4%
Q3 25
-87.6%
37.0%
Q2 25
-108.4%
35.8%
Q1 25
-111.5%
32.5%
Q4 24
-69.4%
33.1%
Q3 24
-98.0%
36.9%
Q2 24
-118.8%
32.1%
Q1 24
-206.0%
32.5%
EPS (diluted)
CVRX
CVRX
FNLC
FNLC
Q4 25
$-0.45
$0.91
Q3 25
$-0.49
$0.81
Q2 25
$-0.57
$0.72
Q1 25
$-0.53
$0.63
Q4 24
$-0.39
$0.66
Q3 24
$-0.57
$0.68
Q2 24
$-0.65
$0.55
Q1 24
$-1.04
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
FNLC
FNLC
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
$95.5M
Stockholders' EquityBook value
$39.3M
$283.1M
Total Assets
$104.8M
$3.2B
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
FNLC
FNLC
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Total Debt
CVRX
CVRX
FNLC
FNLC
Q4 25
$95.5M
Q3 25
$95.5M
Q2 25
$95.0M
Q1 25
$70.0M
Q4 24
$95.0M
Q3 24
$95.0M
Q2 24
$70.0M
Q1 24
$70.0M
Stockholders' Equity
CVRX
CVRX
FNLC
FNLC
Q4 25
$39.3M
$283.1M
Q3 25
$48.1M
$274.6M
Q2 25
$57.9M
$265.5M
Q1 25
$71.1M
$259.7M
Q4 24
$71.1M
$252.5M
Q3 24
$65.2M
$256.8M
Q2 24
$55.2M
$244.7M
Q1 24
$66.3M
$242.6M
Total Assets
CVRX
CVRX
FNLC
FNLC
Q4 25
$104.8M
$3.2B
Q3 25
$111.3M
$3.2B
Q2 25
$119.6M
$3.2B
Q1 25
$129.6M
$3.2B
Q4 24
$133.4M
$3.2B
Q3 24
$127.7M
$3.1B
Q2 24
$96.0M
$3.1B
Q1 24
$106.2M
$3.0B
Debt / Equity
CVRX
CVRX
FNLC
FNLC
Q4 25
0.34×
Q3 25
0.35×
Q2 25
0.36×
Q1 25
0.27×
Q4 24
0.38×
Q3 24
0.37×
Q2 24
0.29×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
FNLC
FNLC
Operating Cash FlowLast quarter
$-9.8M
$37.8M
Free Cash FlowOCF − Capex
$-9.8M
$34.6M
FCF MarginFCF / Revenue
-61.3%
133.9%
Capex IntensityCapex / Revenue
0.4%
12.5%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
FNLC
FNLC
Q4 25
$-9.8M
$37.8M
Q3 25
$-9.7M
$12.9M
Q2 25
$-7.9M
$7.4M
Q1 25
$-12.8M
$2.2M
Q4 24
$-8.0M
$26.0M
Q3 24
$-10.4M
$9.8M
Q2 24
$-9.8M
$6.4M
Q1 24
$-10.9M
$-1.5M
Free Cash Flow
CVRX
CVRX
FNLC
FNLC
Q4 25
$-9.8M
$34.6M
Q3 25
$-10.0M
$12.6M
Q2 25
$-8.0M
$7.2M
Q1 25
$-12.9M
$828.0K
Q4 24
$-8.1M
$24.6M
Q3 24
$-10.4M
$9.6M
Q2 24
$-10.2M
$6.3M
Q1 24
$-11.8M
$-1.8M
FCF Margin
CVRX
CVRX
FNLC
FNLC
Q4 25
-61.3%
133.9%
Q3 25
-68.1%
51.4%
Q2 25
-59.2%
32.1%
Q1 25
-104.3%
3.8%
Q4 24
-52.5%
111.7%
Q3 24
-78.1%
47.0%
Q2 24
-86.3%
32.9%
Q1 24
-109.7%
-9.8%
Capex Intensity
CVRX
CVRX
FNLC
FNLC
Q4 25
0.4%
12.5%
Q3 25
2.0%
1.2%
Q2 25
0.8%
0.6%
Q1 25
0.9%
6.2%
Q4 24
0.3%
6.7%
Q3 24
0.3%
0.5%
Q2 24
3.0%
0.3%
Q1 24
8.5%
1.8%
Cash Conversion
CVRX
CVRX
FNLC
FNLC
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

FNLC
FNLC

Segment breakdown not available.

Related Comparisons